Skip to content
Go to home page
Join
  1. Home
  2. Projects
  3. CONNECT

CONNECT

The Norwegian Precision Cancer Medicine Implementation Consortium (CONNECT) is a public-private collaboration driving the implementation of precision cancer medicine, with Oslo Cancer Cluster as coordinator.

Vector illustration in an aerial view with people sitting in an office around a conference table solving a puzzle.
Photo: Shutterstock

The consortium was initiated by 22 founding partners in December 2020, attracted 6 additional partners since then and is coordinated by Oslo Cancer Cluster.

https://www.connectnorway.org

Questions?

Do not hesitate to contact Andreas Høiaas, project manager, Oslo Cancer Cluster.

CONNECT is a public-private consortium driving the implementation of precision cancer medicine by jointly addressing key obstacles and piloting novel solutions to transform the current practice.

CONNECT gathers all Norwegian university hospitals, pharmaceutical and technology companies, the Norwegian Cancer Society as a patient organisation, the Norwegian Institute of Public Health, the Norwegian Directorate of Health, and the Norwegian Medical Products Agency. The consortium is open to include new partners from the industry and public sector.

Via CONNECT a structured dialogue, information sharing and planning for national precision medicine and diagnostics implementation will be established in line with political guidance and ambitions.

CONNECT is a driver for cross-functional and cross-organizational initiatives, workshops, educational formats and provide access to (international) expertise, experts and benchmarking to advance the implementation of precision cancer medicine.